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Cataract, the loss of ocular lens transparency, accounts for ∼50% of worldwide
blindness and has been associated with water and solute transport dysfunction across
lens cellular barriers. We show that neutral amino acid antiporter LAT2 (Slc7a8) and
uniporter TAT1 (Slc16a10) are expressed on mouse ciliary epithelium and LAT2 also
in lens epithelium. Correspondingly, deletion of LAT2 induced a dramatic decrease
in lens essential amino acid levels that was modulated by TAT1 defect. Interestingly,
the absence of LAT2 led to increased incidence of cataract in mice, in particular
in older females, and a synergistic effect was observed with simultaneous lack
of TAT1. Screening SLC7A8 in patients diagnosed with congenital or age-related
cataract yielded one homozygous single nucleotide deletion segregating in a family with
congenital cataract. Expressed in HeLa cells, this LAT2 mutation did not support amino
acid uptake. Heterozygous LAT2 variants were also found in patients with cataract
some of which showed a reduced transport function when expressed in HeLa cells.
Whether heterozygous LAT2 variants may contribute to the pathology of cataract needs
to be further investigated. Overall, our results suggest that defects of amino acid
transporter LAT2 are implicated in cataract formation, a situation that may be aggravated
by TAT1 defects.
Keywords: amino acid transporters LAT2 and TAT1, gene expression, cataract, ocular tissues, mouse model,
patient screen
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INTRODUCTION
Cataract, the condition of partial or complete loss of transparency
in the ocular lens, is the most frequent cause for vision
impairment worldwide (51%)1. Typically the condition affects
individuals over 50 years of age (McCarty and Taylor, 2001)
and since life expectancy is increasing the number of affected
individuals is raising, for instance in the United States from 24.4
million in 2010 it will change to potentially 50 million in 20502,
making age-related cataract an important socio-economical
problem. Age-related cataract is considered a multi-factorial
disease where both genetic and environmental risk factors
contribute to the pathogenesis (Shiels et al., 2010; Shiels and
Hejtmancik, 2013, 2015). In contrast, early onset cataract, which
is either present at birth or developing within the first few
years of life, affects a minority of patients (∼3–6/10,000 births)
(Graw, 2004; Shiels and Hejtmancik, 2013; Medsinge and Nischal,
2015). Usually this latter type follows Mendelian inherited
patterns where X-linked recessive, autosomal dominant and
autosomal recessive modes of inheritance have been observed
in about 30 different causative genes (Shiels and Hejtmancik,
2013). Routinely, the affected lens is replaced by insertion of
an artificial lens, but existing side effects (Grzybowski and
Kanclerz, 2019; Zhang et al., 2019) motivate for the search of
alternative, non-invasive therapeutic approaches. This requires
detailed understanding of the pathophysiology.
The transparency of the lens is maintained by its unique
physiology and anatomy of tightly packed highly elongated
fiber cells, which lose their organelles during a differentiation
process (Augusteyn, 2010) that continues throughout the entire
lifetime resulting overall in minimal cellular turnover and likely
in the accumulation of metabolic defects that could lead to
loss of transparency. As the lens lacks vasculature, alternative
routes for the supply of nutrients and metabolites from the
bloodstream to the interior of lens cells are required. In
support, the lens is in immediate contact with the aqueous and
vitreous humors. For molecular transport, the ciliary epithelium
represents a first barrier localized between the extracellular space
of the ciliary body and the aqueous humor. This epithelium
is composed of two epithelial cell layers, the pigmented and
the non-pigmented ones, facing each other with their apical
membranes and connected with gap junctions (Raviola and
Raviola, 1978; Figures 1A, 2). Thus, transepithelial transport of
water, ions and nutrients relies on transporters expressed in the
plasma membranes localized on both sides of the paracellular
barrier formed by tight junctions that link non-pigmented
epithelial cell layer together.
A second cellular barrier between blood and lens interior
is formed by the lens epithelium that localizes between the
aqueous humor and the extracellular fluid of the lens and
the tightly packed fiber cells. Water and solutes have thus
to cross the lens epithelial cells and the plasma membrane
of lens fiber cells. These latter cells express next to AQP0
1https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-
impairment
2http://www.nei.nih.gov/health
water channel (aquaporin) (Zampighi et al., 2002) and connexin
(Cx) hemichannels (Shi et al., 2018) also some solute transport
proteins (Truscott, 2000). Accordingly in the lens, that includes
also the aqueous humor-facing lens epithelium, a variety of
transport proteins have been localized, for instance in addition
to aquaporins (Barandika et al., 2016) also ion channels (K+,
Na+, Ca2+), pumps (Na,K-ATPase) (Mathias and Rae, 2004),
glucose transporters (GLUT1, GLUT3, and SGLT2) (Merriman-
Smith et al., 1999, 2003), creatine transporter CRT2 (MCT12)
(Abplanalp et al., 2013) and amino acid transporters (GLYT
AND ASCT2) (Marcantonio and Duncan, 1983, 1987; Lim et al.,
2006, 2007). These latter transporters need to import all amino
acids involved in lens cell metabolism and in particular also
those required for the synthesis of the tripeptide glutathione
(GSH), which is a vital antioxidant known to be important for
the preservation of lens transparency (Giblin, 2000). Another
amino acid that plays a particular role in the lens is L-tryptophan
which is the precursor of several UV filter compounds such
as 3-hydroxykynurenine and 3-hydroxyanthranilic acid (Wood
and Truscott, 1993). The transport of aromatic amino acids like
L-tryptophan and of other large neutral amino acids across the
ciliary epithelium and into the lens presumably involves at least
two transporters, namely LAT2 (Q9UH15, encoded by SLC7A8,
Gene ID: 23428; OMIM 604235) and TAT1 (MCT10, encoded by
SLC16A10). LAT2 is a L-type amino acid transporter associated
with the glycoprotein CD98hc (4F2hc, encoded by SLC3A2),
which exchanges all neutral amino acids against each other with
high affinity at the cell exterior and independent of sodium
(Pineda et al., 1999; Rossier et al., 1999; Meier et al., 2002). In
contrast, the T-type amino acid transporter TAT1, which is also
expressed in the eye3, is a uniporter that has a narrow selectivity
range for aromatic amino acids (Kim et al., 2001; Ramadan et al.,
2006). Based on their abundant co-localization at the basolateral
membrane of the proximal kidney tubule and the small intestine
and also on functional experiments performed in Xenopus laevis
oocytes, LAT2 and TAT1 have been suggested to cooperate
functionally for neutral amino acid (re)absorption (Pineda et al.,
1999; Rossier et al., 1999; Makrides et al., 2014). In a recent study,
we could verify and further extend this hypothesis using a double
KO (dKO) mouse model (Vilches et al., 2018). Importantly, these
transporters are also expressed in sensory organs and defects of
LAT2 have been shown to be involved in age-related hearing
loss (Espino Guarch et al., 2018). The high level of SLC7A8
expression in the eye and in particular in the lens (see text
footnote 3), supported our hypothesis that mutations affect lens
transparency, potentially also with the cooperation of uniporter
TAT1. Here we report association of cataract with LAT2, based
on a homozygous knockout mouse model (Slc7a8−/−) (Lat2
KO) (Font-Llitjós, 2005) in which lens amino acid concentrations
are affected. In accord, we identified a homozygous mutation
in Slc7A8 segregating in a family with congenital cataract.
Whether the heterozygous sequence alterations that were found
in patients with congenital and age-related cataract represent risk
factors will be discussed. Furthermore, in the mouse model that
simultaneous lacks LAT2 and TAT1, the occurrence of cataract is
3https://genome.uiowa.edu/otdb/
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FIGURE 1 | Localization of SLC7A8 (LAT2) and SLC16A10 (TAT1) amino acid transporters in ciliary and lens epithelia of the mouse eye. (A) Schematic drawing of
the mouse eye. (B–D) Localization of LAT2 protein in ciliary epithelium. Paraffin sections of wild type (WT) mouse eyes were stained for LAT2 (green).
(B) Fluorescence image is superposed to the bright field image and (C) nuclei are labeled with DAPI on a dark field. The green staining of LAT2 localizes to the
basolateral side of the dark brown/black pigmented ciliary epithelial cells seen in the bright field (B). (D) Absence of green LAT2 staining in the ciliary epithelium of a
LAT2/TAT1 double KO mouse. (E–H) Localization of TAT1 in ciliary epithelium. (E) RNAscope R© signal of SLC16A10 (TAT1) mRNA (red dots, black arrows) overlaying
the non-pigmented ciliary epithelial cells on a bright field image taken from a wild-type mouse eye cryosection. Pigmented cells appear brown and black.
(F) Fluorescence images of TAT1 (orange/red) superposed to bright field image and (G) together with nuclear DAPI staining on dark field. The orange/red TAT1 signal
localizes to the basolateral side of the non-pigmented epithelial cells. The red/orange signal within the villus is due to erythrocytes. Panel (H) shows the absence of
red TAT1 staining in the ciliary epithelium of a LAT2/TAT1 double KO mouse. (I–L) Localization of LAT2 in lens epithelium. (I) Cryosections of a wild type and (J) of a
LAT2/TAT1 double KO mouse lens, incubated with anti LAT2 antibody (green) that labels the basolateral side of lens epithelial cells facing the anterior chamber (∗) of
a wild type, but not of a LAT2/TAT1 double KO mouse. (K) Paraffin-embedded lens section of a wild type mouse on which Na,K-ATPase alpha subunit (green) and
(L) Na,K-ATPase and LAT2 (red) are labeled. LAT2 is shown to co-localize with Na,K-ATPase (co-staining yellow) at the basolateral side of the lens epithelial layer.
(M–O) Absence of TAT1 in lens epithelium. Panel (M) shows the absence of TAT1 mRNA signal by RNAscope R© (no pink dots), in a wild type mouse lens epithelium.
(N) Absence of TAT1 immunofluorescence signal (green) on wild type and (O) LAT2/TAT1 double KO mouse lens cryosections.
increased, suggesting synergistic effects. Taken together, a model
emerges proposing that defects of LAT2-mediated amino acid
transport can influence cataract formation.
MATERIALS AND METHODS
In situ RNA Hybridization
RNA molecules were detected in situ by using the RNAscope R©
technology (Advanced Cell Diagnostics, Newark, CA,
United States) according to manufacturer’s guidelines. Whole
eyes were fixed in 3% PFA for 24 h and paraffin embedded.
5 µm sections were mounted on Superfrost Plus slides and
deparaffinized before being pre-treated as follows: 10 min in
Hydrogen Peroxide, 5 min incubation in the boiling Target
Retrieval Solution and 30 min incubation with Protease Plus
at 40◦C. The slides were then subjected to the RNAscope R© 2.5
HD Assay-Red, strictly following manufacturer’s instructions,
using the probe named Mm-Slc16a10-O1 targeting 483–1560
of NM_028247.4. At the end of the procedure, slides were
counterstained, dried in a 60◦C oven for 1 h, dipped in
Xylene and mounted with VectaMount (Vector Laboratories,
Burlingame, CA, United States). Sections were imaged using a
brigthfield microscope (Nikon Eclipse TE300, Nikon Instruments
Inc., Melville, NY, United States).
Immunofluorescence
Eyes were extracted as described below and fixed in 3%
paraformaldehyde (PFA) for 24 h embedded in paraffin blocks.
Lenses were snap frozen and later mounted in OCT. Paraffin
sections of the whole eye (5 µm) and cryosections of the
lenses (6 µm) were prepared. Sections were incubated with
primary antibodies (diluted in PBS, 2% BSA, 0.04% Triton X-100)
overnight at 4◦C. Subsequently, sections were incubated with the
appropriate secondary antibodies (Supplementary Table S1) and
mounted in Glycergel (DakoCytomation, Denmark). Sections
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FIGURE 2 | Changes in amino acid concentrations in serum, aqueous humor and lenses caused by the KO of LAT2 and the dKO of LAT2 and TAT1. Schematic
drawing of ciliary and lens epithelia: The ciliary epithelium is composed of two cell layers facing each other with their apical sides that are linked by gap junctions. The
cell layer at the vascular side forms the pigmented epithelium (gray) and the cell layer facing the aqueous humor the non-pigmented one (white) which, with its tight
junctions prevents paracellular diffusion between the extracellular space of the ciliary body and the aqueous humor (see also Figure 1). LAT2 localizes to the
basolateral surface of ciliary pigmented epithelial cells and to the basolateral side of lens epithelial cells, whereas TAT1 localizes to the basolateral side of the
non-pigmented cell layer of the ciliary body and is absent from the lens. The impact of the single LAT2 (red) knockout and of the double KO of LAT2 (red) and TAT1
(blue) on amino acid concentrations in the different compartments is indicated as lists of amino acids that are significantly up- (↑) or down- (↓) regulated. Statistical
significance of the difference with wild type calculated by one way ANOVA followed by Bonferroni post-test: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. The actual mean
concentrations for all proteinogenic amino acids in the four genotypes is given in Supplementary Table S3.
were viewed on a Nikon Eclipse TE300 epifluorescence
microscope (Nikon Instruments Inc., Melville, NY) equipped
with a DS-5M Standard charge-coupled device camera (Nikon
Instruments Inc.) and acquired with NIS Elements (Nikon
Instruments Inc.). Images were merged using Photoshop 9.
Collection of Mouse Serum, Aqueous
Humor and Lenses for Amino Acid
Quantification by Ultra-Performance
Liquid Chromatography (UPLC)
Wild type, heterozygous and homozygous mice were anesthetized
with AttaneTM (Isoflurane, Piramal Critical Care, Germany) for
heart blood collection. Immediately after this terminal bleeding,
the aqueous humor was collected using a 30-gauge needle
and the lenses were isolated as described below. Amino acid
analysis was performed at the Functional Genomics Center
Zurich (FGCZ). Samples were deproteinized with sulfosalicylic
acid (5% final concentration), and amino acid concentrations
were determined using the MassTrak Amino Acid Analysis
Solution method (Waters, Milford, United States) according to
the manufacturer’s instructions.
Mouse Models and Cataract Scoring
Genetically modified animals involved in this study included
LAT2 KO mice (Font-Llitjós, 2005) and TAT1 KO (Mariotta et al.,
2012); both are loss-of-function models [Slc7a8 (LAT2) with
deletion of exon 1 and Slc16a10 (TAT1) with non-sense mutation
leading to a premature stop at position 88]. Additionally,
LAT2/TAT1 double knockout (dKO) mice were generated by
crossing TAT1 KO with LAT2 KO animals. Both knockout
models have pure C57BL/6 genetic background. It has been
reported that the C57BL/6J genetic background carries the
potential for embryonic developmental eye problems, which
may result in anophthalmia, microphthalmia and corneal and
lenticular opacities at low frequency (Pierro and Spiggle, 1967;
Kalter, 1968; Cook and Sulik, 1986). Therefore, the statistical
evaluation was in comparison to wild type (WT) siblings.
Animals were anesthetized with AttaneTM and immediately
euthanized by terminal bleeding via cardiac puncture. Eyes were
then extracted and kept in ice-cold PBS solution on ice during the
entire procedure. Lens of animals aged between 2 and 19 months
were removed either through the opened cornea or posteriorly
through the opened eye near the optic nerve. As we did observe
some developmental morphological abnormalities of the lens as
well as normally shaped lenses with opacities, the number of
animals that was investigated in our study was increased. In
the control group of 97 WT eyes, cataract was observed in 3%.
Cataract (opacities in the lens) was scored first in vivo, then
ex vivo after eye dissection, followed by a microscopic analysis
(Leica Z16 APO) of the lens. Lenses were placed on EM copper
grid, 200/inch mesh, in order to evaluate their transparency. To
avoid biased analysis, cataract assessment was performed blinded
with respect to the animal genotype, age and gender. Animals
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were bred at two facilities: at the University of Zurich, Switzerland
and at the IDIBELL in Barcelona, Spain. Food and water were
given ad libitum.
Patients Diagnosed With Cataracts
Patients’ cataract condition and their DNA samples were
provided from three clinical sources: Switzerland (family D
and 132 patients with juvenile cataract and 360 patients with
age-related cataracts, all diagnosed by Dr. F. Munier), the
United Kingdom (95 samples from probands, all with autosomal
dominant inherited childhood cataracts, diagnosed by Dr. A. T.
Moore), and Canada (81 patients with cataracts of various age of
onset, diagnosed by Dr. E. Heon).
DNA Sequence Analysis of SLC7A8
Exons
Genomic DNA from patients diagnosed with either juvenile or
age-related cataract was amplified using primers for coding exons
1 to 11 of the gene SLC7A8 (Entrez ID 23428, NM_22244.3,
OMIM 604235) (Sequence and annealing temperature in
Supplementary Table S2). PCR amplification of 35 cycles, 1 min
for each step was followed by Sanger sequencing reactions using
ABI chemistry (BigDye version 1), hardware (DNA analyzer 3730
or Genetic Analyzer 3130xl and software (SeqScape) (Applied
Biosystems, Risch-Rotkreuz, Switzerland). PCR and sequencing
of samples showing rare sequence variants was repeated. Variants
were annotated using Alamut-HT (Interactive Biosoftware,
Rouen, France). Frequencies were taken from dbSNP and Exome
Aggregation Consortium (ExAC) data base (May 2018) (for web
site links see below).
Site-Directed Mutagenesis
The QuikChange site-directed mutagenesis kit (Agilent, Santa
Clara, CA, United States) was used to introduce point mutations
in LAT2 sequence, according to the manufacturer’s protocol.
The pcDNA3.1-StrepTag fused LAT2 construct (N-terminally
tagged) was used as template (Costa et al., 2013). Amino
acid substitutions were introduced into LAT2 sequence using a
compatible reverse primer and forward primers (Supplementary
Table S2). All primers annealed to the coding sequence,
and the position of the mutated codon was underlined. All
constructs were verified by DNA sequencing and then used for
transient transfection.
Cell Culture and Transfection
HeLa cells were maintained at 37◦C/5% CO2 in Dulbecco’s
modified Eagle’s medium (Life Technologies, Carlsbad, CA,
United States) supplemented with 10% (v/v) fetal bovine
serum, 50 units/ml penicillin, 50 µg/ml streptomycin, and
2 mM L-glutamine. HeLa cells were transiently co-transfected
with plasmid constructions mentioned (0.2 µg cDNA/well of
24-well plate) above (or empty vector for mock cells) and
human His-CD98hc (His-4F2hc) (N-terminally tagged) cloned
in pcDNA4His-MaxC (0.2 µg cDNA/well of 24-well plate) (Fort
et al., 2007) with the use of Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, United States) following the manufacturer’s
protocol as described (Rosell et al., 2014). Amino acid transport
and fluorescence microscopy analyses were carried out 48 h
after transfection.
Amino Acid Transport Assay
Amino acid uptake was measured by exposing replicate cultures
at room temperature to [3H]-labeled alanine, [3H]-tryptophan
or [3H]-isoleucine (1 µCi/ml; Perkin Elmer, Waltham. MA,
United States) in sodium-free transport buffer (137 mM choline
chloride, 5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, and 10 mM
HEPES, pH 7.4). Initial rates of transport were determined using
an incubation period of 1 min and 50 µM of cold amino
acid. Assays were terminated by washing with an excess volume
of chilled transport buffer. Cells were lysed using 0.1% SDS
and 100 mM NaOH. Then 200 µL were used for radioactivity
counting in a Packard Tri-Carb Liquid Scintillation Counter,
and 15-µL duplicates were used to determine protein content
using the Pierce BCA kit, Pierce. Uptake values were corrected by
cellular protein in all cases, and by the expression of Strep Tagged
LAT2 by fluorescence microscopy (Total corrected Cellular
Fluorescence, TCCF; see next section) for all constructs except
for mutant F436Sfs∗22 that showed compromised expression
compared with reference LAT2.
Visualization of Strep-Tagged Amino
Acid Transporters by Fluorescence
Microscopy
To analyze the effect of the mutations on LAT2 protein expression
and plasma membrane localization, fluorescence microscopy of
Strep-tagged reference and mutant transporters was performed
on a semi confluent monolayer of transfected HeLa cells cultured
on glass coverslips. Glass coverslip-grown cells were incubated
with 1 mg/ml wheat germ agglutinin (WGA) labeled with Texas-
Red (Thermo Fisher Scientific, Waltham, MA, United States) at
37◦C for 10 min, rinsed three times with phosphate-buffered
saline-Ca2+-Mg2+ and fixed for 15 min in 4% paraformaldehyde.
Fixed cells were blocked in blocking buffer (10% FBS and
0.1% saponin in PBS) for 1 h and then incubated for 1 h
with primary antibody (anti-Strep Tag GT517, 1/100; Abcam,
Cambridge, United Kingdom). Secondary goat-anti-mouse-FITC
antibody (Life Technologies, Carlsbad, CA, United States) was
incubated for 2 h protected from light and rinsed three
times with phosphate-buffered saline. Nuclear staining was
performed by incubating 1 µg/ml Hoechst (Thermo Fisher
Scientific, Waltham, MA, United States) for 10 min, rinsed
three times with phosphate-buffered saline and then mounted
with aqua-poly/mount coverslipping medium (Polysciences, Inc.,
Warrington, PA, United States). Images were taken using a
Nikon E1000 upright epifluorescence microscope. All images
were captured during 200 ms with the exception of those
corresponding to p.Phe436Serfs∗22 that was overexposed to 2 s,
to reveal the subcellular localization of this very low expressing
variant. To quantify LAT2 reference control and mutated
transporters expression levels in cells, a single in-focus plane
was acquired. Using ImageJ (v1.48, NIH), an outline was drawn
around each cell and area and mean fluorescence measured, along
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with several adjacent background readings. The total corrected
cellular fluorescence (TCCF) = integrated density – (area of
selected cell × mean fluorescence of background readings), was
calculated (Conway et al., 2016).
Statistics
Pooled data are shown as means ± SEM (n) where n represents
the number of independent experiments (n = 3 for uptake
experiments in HeLa cells, passage 10–12 in the laboratory) in
each of 4 replicas. For statistical comparison, ANOVA (Analysis
of Variance) followed by Bonferroni post-test or Two-tailed t-test
were performed using a statistical software package (Prism v.
5.0–7.0, GraphPad, San Diego, CA, United States) or R, a free
software for statistical computing. Odds ratio and Fisher Exact
Probability Test were calculated using the online calculator from
Vassar College4.
Study Approval
All animals were kept in accordance with the Swiss and Spanish
federal law, respectively, and experiments were performed with
the approval of the Swiss Veterinary Council and with the
approval of the Animal Experimentation Ethics Committee at
the IDIBELL (AAALAC accredited facility, B99000010) and
by the corresponding department of Generalitat of Catalunya
(DAAM#3866). Patients’ participation in this study was approved
by the respective ethics regulatory bodies and all patients gave
written informed consent. Experiments respected the principles
expressed in the Declaration of Helsinki.
Web Resources
Web sites for sequence information and prediction programs.
Alamut Visual vs2.7.2, a mutation analysis software5.
DNA and protein sequence information GeneCards http:
//www.genecards.org/ and NCBI http://www.ncbi.nlm.nih.gov/
and UniProtKB http://www.uniprot.org/uniprot. SNP variant
information: ESP Exome variant server http://evs.gs.washington.
edu/. ExAC http://exac.broadinstitute.org/ and Ensemble
v83 http://www.ensembl.org/index.html. Gene expression
https://genome.uiowa.edu/otdb/, https://genevestigator.com/gv/
and https://mae.hms.harvard.edu/. Online calculator from
Vassar College (see text footnote 4).
RESULTS
Expression and Localization of Slc7a8
(LAT2) and Slc16a10 (TAT1) Amino Acid
Transporters
To determine the localization of the neutral amino acid exchanger
LAT2 and the aromatic amino acid uniporter TAT1 in mouse
eyes, we performed immunofluorescence and RNA in situ
hybridization experiments on tissue sections of the ciliary body
and the ocular lens from wild type and knockout (KO) animals
(Figure 1). On the ciliary body of wild type animals, LAT2
4http://vassarstats.net/tu.html
5http://www.interactive-biosoftware.com/alamut-visual/
protein was detected at the basolateral side of the pigmented
epithelial layer, which forms the blood side border of the
double-layered ciliary epithelium (Figures 1B,C). The specificity
of this strong signal was confirmed by its absence in LAT2/TAT1
double KO animals (Figure 1D). In contrast, TAT1 was detected
at the mRNA and protein levels in the non-pigmented cell
layer of the ciliary epithelium that faces the aqueous humor
(Figures 1E–G). The absence of TAT1 protein in the ciliary
bodies of LAT2/TAT1 double KO confirmed antibody specificity
(Figure 1H). Interestingly TAT1 protein appeared to localize to
the aqueous humor facing basolateral side of these cells. Within
the lens, a strong LAT2 signal localized to the basolateral side of
the lens epithelium where it co-localized with the Na,K-ATPase
(Figures 1I,K,L). Also in this case the specificity of the signal
was confirmed by its absence in lenses of double KO animals
(Figure 1J). In contrast, TAT1 was absent from the lens both
at the mRNA level (no hybridization signal in Figure 1M and
no qPCR signal, data not shown) and at the protein level (no
immunofluorescence signal, Figures 1N,O). These LAT2 and
TAT1 expression patterns observed in mouse eye fully correspond
to the mRNA expression levels reported for human eye, namely
equally high levels of LAT2 and TAT1 mRNA in ciliary body and a
very high level for LAT2 and a near-absence of TAT1 in the lens6.
No significant difference of the staining pattern was observed in
heterozygous and wild type animals (Supplementary Figure S1).
In summary, the expression of LAT2 or TAT1 on both sides of
the ciliary epithelium and of LAT2 on the aqueous humor-facing
basolateral side of the lens epithelium support the hypothesis that
these transporters play an important role for the transport of
amino acids from the blood to the lens and thus for lens amino
acid homeostasis.
Effect of LAT2 and TAT1 Knockout
Mutations on Amino Acid Composition in
Serum, Aqueous Humor and Lens in
Mice
Disruption of the neutral amino acids exchange performed
by the antiporter LAT2 and of the facilitated diffusion of
aromatic amino acids mediated by the uniporter TAT1 has
been shown to affect not only the homeostasis of immediate
transporter substrate amino acids but also to strongly impact
the general amino acid balance (Vilches et al., 2018). Such
profound misbalance of amino acid concentrations is what we
observed when we analyzed amino acid levels in the serum,
aqueous humor and lens from LAT2 and double KO mice
(Figure 2 and Supplementary Table S3) and compared them
with findings from wild type animals. Figure 2 displays the
sequential barriers that limit the circulation between blood and
lens, namely the double layered ciliary epithelium that separates
the blood side extracellular space from the aqueous humor and
the lens epithelium, which forms the barrier toward the lens
extracellular space. As previously described, the lack of LAT2
slightly influences the concentration of some serum amino acids
(Val, Ile, Thr, and Lys levels significantly increased), whereas
the additional absence of TAT1 leads to a strong and significant
6http://genome.uiowa.edu/otdb
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increase of the aromatic amino acids Tyr and Trp, as in TAT1
single KOs (Mariotta et al., 2012; Vilches et al., 2018). More
striking, amino acid concentration changes relative to the wild
type situation are observed in the aqueous humor, which is
largely produced by the ciliary epithelium that lacks LAT2 on
the blood facing side (Figure 2) and, in the case of the double
KO, also TAT1 on the aqueous humor facing basolateral side.
Interestingly, although the amino acid concentration changes
were significant in both genotypes, they were quite different from
each other. In contrast, the impact of the lack of LAT2 was
clearly dominant in the lens, as amino acid levels were quite
similarly affected in double KOs. Importantly, the concentration
level of nearly all essential amino acids was strongly decreased
in lenses of both genotypes (statistically significant decrease in
LAT2 KO of Val, Leu, Ile, Met, Phe Tyr Trp, Arg, and His)
whereas some non-essential amino acids were increased (Ala,
Ser, and Gln). Interestingly, the decrease of essential amino acids
was quantitatively even more pronounced in double KO lenses
where in most cases levels were reduced to <50% of the control,
whereas amino acid levels were not altered in LAT2 heterozygous
mice (Supplementary Table S4). Taken together, these results
show that the absence of LAT2 leads to a strong imbalance
of the normal amount of amino acids in the lens, which is
further exacerbated when TAT1 is missing. They further suggest,
that only severely reduced levels of functional transporter may
lead to a phenotype and that a single functional LAT2 allele
under certain physiological conditions may support normal
lens physiology.
Cataracts in Slc7a8 (LAT2), Slc16a10
(TAT1) and Double KO Mice
A possible impact of LAT2 and TAT1 knockout on the prevalence
of cataract phenotype was evaluated. Initial assessment of lens
opacities was performed in the living animal (Figures 3A,B).
Upon sacrificing the animals, eyes were enucleated and the lenses
were inspected microscopically for transparency (Figure 3C) and
varying degrees of opacities (Figures 3D–F). Mature cataract
was often associated with reduced size of the lens (Figure 3F).
The result of this morphological assessment of lenses taken from
knockout mice lacking LAT2 (LAT2 KO) either alone or in
combination with the TAT1 (dKO) was compared to that of their
wild type (WT) littermates and of TAT1 KO mice. A total of 97
WT, 48 LAT2 KO, 128 TAT1 KO, and 74 dKO eyes were examined
(Supplementary Figure S2). The number of cataract occurrence
per genotype is shown in Figure 4 and statistical significance is
based on odds ratio calculations. In comparison to the wild type
animals, the absence of LAT2 (LAT2 KO) alone and together with
that of TAT1 (dKO) resulted in a statistically significant higher
frequency of cataract occurrence in old animals (p = 0.016 and
p = 0.0012, respectively), specifically in old females (p = 0.0187
and p = 0.0017, respectively) (Figure 4 and Supplementary Table
S5), suggesting that the loss of LAT2 represents a risk factor
for cataract in aging animals. Increased frequency of cataract
was observed when TAT1 was also missing (dKO) and affected
both age groups and sexes. However, the lack of TAT1 KO alone
did not seem to influence cataract formation. Taken together,
simultaneous absence of both transporters leads to increased
occurrence in cataract in all groups, while the lack of LAT2 alone
was sufficient to result in a significant increase of cataracts in old
animals, in particularly in old females.
Screening of Sequence Variants in the
Coding Region of SLC7A8 in Patients
With Cataracts
Based on the strong association of Slc7a8 with cataract in
the mouse model, SLC7A8 became a potential candidate gene
for human cataract as well. Furthermore, the statistically
non-significant different results of amino acid concentrations
FIGURE 3 | Assessment of cataract in mice. Examples of mice (A) without cataract showing top and side view and (B) with unilateral (right eye) cataract.
Microscopic view of extracted lenses placed on copper grid (200/inch mesh) to visualize opacities with examples of (C) a transparent lens, (D) mild opacity, (E)
intermediate opacity, and (F) mature cataract.
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FIGURE 4 | Effect of genotype on cataract formation in mice. Genotypes are given on X-axis: wild type (WT), single (TAT1 and LAT2 knockouts) and double KO.
Number of lenses assessed on Y-axis with either cataracts (black bars) or no cataract (light bars). (A) Young animals; (B) Old animals; (C) Old females; (D) Old
males. For statistical evaluation mutants were compared to wild type (WT) animals. Statistical significance is displayed as: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001,
∗∗∗∗P < 0.0001 (see Supplementary Table S5).
in wild type and heterozygous LAT2 mutants (Supplementary
Table S4) suggested to search in particular for homozygous
sequence alterations. Although the observations in mice
suggested a stronger association with late- than early onset
cataract, we included 308 patients with childhood (congenital)
cataract and 360 patients diagnosed with age-related cataract
(ARC) in the screen for sequence variants in the coding region
and canonical splice sites of SLC7A8. We found one homozygous
alteration: a deletion of one nucleotide leading to a Frameshift
and a premature termination toward the carboxy terminus of
the translated protein (c.1305del; p.Phe436Serfs∗22). In the SNP
databases, this variant (rs778197019) was not found in the coding
transcript of SLC7A8; only in a non-coding transcript variant,
without indication of its frequency (Supplementary Table S6).
In the family both affected siblings (II-1 and II2 in Figure 5A) are
homozygous for this variant while the parents are heterozygous.
Consanguinity was not indicated.
The proband (II-1 in Figure 5A) had been diagnosed
with bilateral congenital sutural and zonular cataract, which
was operated at 6 and 8 weeks of age. While a younger
sibling was also diagnosed with this cataract, both parents
were unaffected.
Functional Studies for Uptake of Amino
Acids
This homozygous alteration was reconstructed and tested in
the human HeLa cell model for amino acid uptake. Both,
the reference (wild type) and the variant LAT2 catalytic
light chains were co-expressed with the glycoprotein subunit
[CD98hc (4F2hc)] to increase their potential plasma membrane
localization (Rosell et al., 2014). The lack of membrane staining
upon expression of the variant LAT2 is in line with the observed
lack of amino acid transport (Figures 5B,C).
Taken together, the functional tests of the LAT2 mutation
in Hela cells combined with the cataract diagnosis of the two
homozygous patients strongly suggest a correlation in humans
between LAT2 defect and cataract.
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FIGURE 5 | SLC7A8 mutation Phe436Serfs∗22 in cataract patients and its effect on function. (A) Pedigree (two generation family) of proband with congenital
cataract. Both affected children (II-1 and II-2) (filled symbol) carry a homozygous deletion of nucleotide c.1305C leading to the Frameshift p.Phe436Sers∗22. Both
unaffected parents (unfilled symbol) are heterozygous for the mutation. Arrow points to the position of the deletion. The reference sequence in the electropherogram
shown reads 5′-GAAGGCCCAGAACA-3′. (B) Alanine (black bars), tryptophan (white bars), and isoleucine (gray bars) uptake of cataract associated sequence
variant F436Sfs∗22 in SLC7A8, tested in HeLa cells. Uptake mean and standard error of mean (SEM) were calculated in relation to the reference uptake.
(C) Subcellular localization of Strep tagged hLAT2 and cataract variant pPhe436Serfs∗22 in HeLa cells. Green staining: LAT2, red staining: wheat germ agglutinin,
blue (DAPI) staining: nuclei and merged showing co-localization with the plasma membrane marker for reference LAT2 but not for pPhe436Serfs∗22, which does not
co-localize with plasma membrane, indicating that this variant is retained intracellularly. (D) Location of the frameshift mutation Phe436Serfs∗22 within the structure
of human LAT2. Cartoon representation of the structural homology model of human LAT2 (Rosell et al., 2014) in an outward-facing conformation, based on the
atomic structure of the bacterial homolog AdiC (Gao et al., 2010; Kowalczyk et al., 2011). Unwound segments of TM domains 1 (TM1) and TM6 that interact with the
α-amino-carboxyl end of the amino acid substrates are colored in blue and red, respectively. The frameshift mutation Phe436Serfs∗22 produces a new 21 amino acid
long carboxy terminus that replaces the yellow labeled last 100 amino acids that encompass for instance the end of TM11 and the last TM domain of LAT2 (TM12).
DISCUSSION
We have shown that the lack of functional LAT2 provokes
a strong decrease of lens essential amino acid levels in mice
and furthermore associates with cataracts in both, mice and
humans. The localization of LAT2 on the blood facing side of the
pigmented ciliary epithelium and on the aqueous humor-facing
side of the lens epithelium explains the strong decrease in
lens essential amino acid content observed in LAT2 KO mice
(Figures 1, 2). Also, the fact that LAT2 functions as amino acid
antiporter mediating the influx of extracellular essential amino
acids mainly in exchange with the eﬄux of highly concentrated
intracellular non-essential amino acids (Pineda et al., 1999;
Meier et al., 2002) agrees with the observed increase of some
non-essential amino acids in the lens of LAT2 KO mice. The
localization of TAT1 at the aqueous humor side of the ciliary
epithelium is also in line with the effects observed at the level
of the lens essential amino acids in the double KO mice, where
we observed mostly a stronger decrease than in the LAT2 KOs
(Supplementary Table S3). It has to be mentioned though
that TAT1 KO per se leads to elevated plasma aromatic amino
acids, explaining the less drastic effect of the double KO on
this class of essential amino acids compared for instance to the
branched chain ones.
As described above, the knockout of mouse LAT2 was
associated with ARC, in particular in female animals, and the
additional defect of TAT1 strengthened this association. Based
on these results, it appears that their might be a causative link
between the decrease in lens amino acids and the development of
cataract. Indeed, an important function of the amino acids within
the lens may be to serve the metabolic needs of the epithelium
and the differentiated fiber cells (Swarup et al., 2018). These
authors found for instance a substantial change in amino acid
concentrations upon deletion of the energy providing glucose
transporter GLUT1. The depletion of tryptophan, a specific
essential aromatic amino acid, might play an important role for
the pathogenesis of cataract. We report here a significant effect
on tryptophan in the mouse eye, and in rats, it was shown that
a tryptophan-restricted diet resulted in altered lens structure
(McAvoy et al., 1979). Specifically, fiber cell differentiation was
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accompanied with slowing the process of nuclei breakdown
(Vrensen et al., 2004). Furthermore, tryptophan was shown
to play an important role in the lens’ response to UV light
(Wood and Truscott, 1993) and it has long been known that
exposure to UV light is an environmental risk factor for cataract
(Roberts, 2001, 2011). Lens contain several molecules that absorb
UVA light (320–400 nm) one of which is tryptophan-derived
3-hydroxykynurenine O-β-D-glucoside (3OHKG) (Gad et al.,
2014). This protective molecule has been reported to decrease
with age, potentially further promoting age-related loss of
lens transparency.
Screening the LAT2 gene of 308 human patients with
childhood (congenital) cataract and 360 with ARC we identified
in two siblings with congenital cataract a homozygous LAT2
variant. This variant is a single nucleotide deletion leading
to a Frameshift with premature termination of the translated
protein (c.1305del; p.Phe436Serfs∗22) and its expression in
HeLa cells showed a lack of surface expression and amino
acid transport (Figure 5). In view of possible structural
changes introduced by the frame shift, should the aberrant
mRNA not be removed by non-sense mediated decay, LAT2
protein may present with an altered C-terminus starting at the
extracellular end of trans-membrane domain TM11 and lacking
TM12. It has to be mentioned that both heterozygous parents
had not developed cataract at the time of the investigation.
Furthermore, we identified six heterozygous variants in 10 other
patients with congenital or childhood cataract and four variants
in nine patients with ARC (Supplementary Figure S3 and
Supplementary Table S6). Two of these variants (p.Ala94Thr
and p.Ser29Phe) were found multiple times in both groups of
cataract patients (Figure 5A and Supplementary Table S6). The
frequency of these variants in each group is statistically not
significantly different from each other (9/360 with ARC and
11/308 with early onset cataract; p = 0.2795).
Whereas the association of the homozygous mutation
blocking LAT2 function with congenital cataract in two siblings
strongly suggests a causative relationship between the LAT2
defect and cataract, it is less clear whether heterozygous variants
of LAT2 identified in early and late onset cataract patients
participate in the pathogenesis. Given our findings that in
mice the heterozygous lack of LAT2 had no measurable effect
on LAT2 expression in ciliary and lens epithelia observed
by immunofluorescence nor on amino acid concentrations in
aqueous humor and lens, it seems likely that only strong defects
in amino acid transport may be a risk for cataract formation.
Interestingly, testing the transport function of the heterozygous
variants in HeLa cells showed that all but two of them transported
the tested amino acids (Ala, Trp, Ile) either as well as wild type
LAT2 or with a reduction of less than 50% (Supplementary
Figure S3). Two variants, p.Val302Ile and p.Ala94Thr displayed a
stronger reduction of transport specifically for the large aromatic
amino acid Trp (∼75% reduction) and both map to the protein
core of LAT2. Of note is that variant p.Val302Ile plays a role
in age-related hearing loss in which it was shown to display a
reduced transport rate of another aromatic amino acid, tyrosine
(Espino Guarch et al., 2018). The fact that the variants reported
here show no or little effect on the uptake of alanine and
isoleucine in our HeLa cell model is interesting and worth
further studies. Taken together, these functional experiments do,
for most of the identified heterozygous variants, not provide
strong support for their involvement in cataract pathogenesis.
In contrast, for the two variants that display strongly decreased
Trp transport implication in pathogenesis of cataract appears
more plausible since low levels of tryptophan or of other essential
amino acids may lead to accelerated lens aging and, as a possible
consequence, to the development of cataract.
Nevertheless, as age related cataract is a multifactorial disease,
interactions with other genes or factor are likely involved
in the manifestation of the phenotype and in combination,
single allele defects may contribute. The presence and hence
possible effects of additional sequence variants in either known
or yet unknown cataract genes in any of the patients cannot
be excluded. A candidate gene for such additional variant
is SLC16A10 encoding the aromatic amino acid transporter
TAT1, in particular since our mouse studies suggest synergistic
effects of TAT1 and LAT2. In an initial search, we screened
the DNA from patients with variants in SLC7A8 for variants
in SLC16A10 and identified several, which require further
functional analyzes in order to understand their possible
molecular interactions (unpublished data).
The question of gender bias in cataract is difficult to assess
and is only indirectly measured by the number of surgeries.
For age-related cataract a preponderance of females has been
reported (Rao et al., 2011), but reasons are likely complex and
could be based among others on socio-economic and cultural
conditions. Nevertheless, a genetic component may also influence
the impact on gender and a possible factor could be related to the
amino acid transporters LAT2 and TAT1 where we found a higher
frequency of cataract among old females in the animal model, and
moreover, all ARC patients with heterozygous SLC7A8 variants
were also females. Whether these genes carry genetic risk factors
affecting a gender bias will await further studies. With respect to
aging, the evidence provided here in combination with a recent
report that LAT2 is involved in age-related hearing loss (Espino
Guarch et al.), suggests that this gene likely influences a genetic
risk for sensory processes during aging.
CONCLUSION
In conclusion, the identification of sequence variants in the
amino acid transporter LAT2 in mouse models and in humans
supports SLC7A8 as a novel cataract gene. The amino acid
transporter TAT1 has a modifying influence on cataract
formation as shown in double KO mice. Thus, it appears that
amino acid imbalance could contribute to the explanation of
a pathomechanism of lens opacification. It is expected that
additional transporters with function in the lens will also be
implicated in murine and human cataract.
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CONTRIBUTION TO THE FIELD
We show in this paper that the transporter LAT2 (Slc7a8)
plays a crucial role for ocular lens amino acid homeostasis
in mice and that its defect favors the development of lens
opacification. In agreement, strong LAT2 expression was
observed in ciliary body and lens epithelia. In human, we
identified a variant of SLC7A8 that segregates recessively in
a family with childhood cataract. It encodes a truncated
LAT2 protein that displayed defective amino acid transport
when expressed in HeLa cells. Additional heterozygous variants
were found in patients with either childhood or age-related
cataract. Recently, a report demonstrated the relevance of
LAT2 function in hearing, as mutations are associated with
age-related hearing loss. This suggests the possibility that
altered amino acid homeostasis may also affect other sense
organs and could be implicated in other eye diseases such
as retinal degenerations or glaucoma. Hence, it is suggested
that understanding amino acid homeostasis and effects of its
imbalance represents a crucial contribution to understanding
numerous biomedical conditions.
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